Trials show Oxford's COVID vaccine works well in older adults
Scientists working with AstraZeneca say they're "delighted" with the latest human trial data, but they're "not in a rush."
Pfizer
Immunologist: "There are dark days ahead"
Pfizer and Moderna have announced their coronavirus vaccines appear to be about 95% effective, as states across the U.S. continue to grapple with a surge in cases and hospitalizations. CBS News correspondent David Begnaud reports, and internal medicine specialist and immunologist Dr. Neeta Ogden joins CBSN to discuss what local officials should have done to avoid reaching this point, and what they can do now.
Vaccines show promise as COVID cases rise
Pfizer and its partner BioNTech announced plans to apply for FDA emergency use authorization for their vaccine candidate, after test results showed it was 95% effective at preventing COVID-19. CBS News' Danya Bacchus reports, and then New York Times' "Matter" columnist Carl Zimmer joins CBSN's "Red & Blue" anchor Elaine Quijano to discuss the impact of the coming vaccines.
Coronavirus death toll in U.S. surpasses 250,000
Hospitals throughout the country are being overwhelmed and the nation's largest public school system in New York City has gone back to remote learning.
Pfizer says vaccine 95% effective, will seek FDA's okay "within days"
It's the latest hopeful news for a world desperate to turn the tide on the coronavirus pandemic that has killed more than 1.3 million people globally, and almost 250,000 in the U.S. alone.
11/17/20: Red and Blue
Biden builds staff while Trump blocks transition; Sydney Barber makes history at U.S. Naval Academy
States tighten COVID restrictions amid rise in cases
More than 11.3 million coronavirus cases have been confirmed across the U.S. As both cases and hospitalizations continues to rise, officials in at least 28 states are tightening COVID-19 related restrictions in an effort to curb the spread of the virus. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University Bloomberg School of Public Health, joins CBSN's Elaine Quijano to discuss.
What to know about COVID vaccine trials
The nation's top infectious disease expert, Dr. Anthony Fauci, says as many as 20 million Americans could get a COVID-19 vaccine by the end of 2020. Dr. Uché Blackstock, an emergency physician and founder of the group Advancing Health Equity, joins CBSN's "Red & Blue" host Elaine Quijano to discuss the encouraging early results from vaccine trials by Moderna and Pfizer.
Pfizer faces hurdles in distributing vaccine
Early excitement for a coronavirus vaccine may be dampened by the reality of transporting millions of doses to recipients across the U.S. and around the world. CBS MoneyWatch senior reporter Stephen Gandel joins CBSN AM to discuss some of the issues Pfizer will face in getting its vaccine distributed.
Distributing Pfizer's vaccine will be a "logistical nightmare"
Vaccine "suitcases" can only be opened for 180 seconds at a time. Experts say many doses could go to waste.
Moderna's COVID-19 vaccine is 94.5% effective
American pharmaceutical company Moderna announced on Monday that its COVID-19 vaccine candidate is nearly 95% effective. The news comes one week after Pfizer announced its inoculations are also successful. CBS News chief medical correspondent Dr. Jon LaPook has the latest.
Moderna vaccine shows success in testing
Moderna says preliminary results show its coronavirus vaccine is over 94% effective. CBS News correspondent Carter Evans reports on the latest developments, and emergency care physician Dr. Ron Elfenbein joins CBSN to discuss progress towards a vaccine and the challenges involved in distributing it to millions of people nationwide.
COVID-19 cases spike across U.S.
Moderna says its coronavirus vaccine candidate is more than 94% effective in preliminary data from clinical trials. The news comes as the U.S. surpassed a total of 11 million cases of COVID-19. Reporter Bofta Yimam joins CBSN AM to talk about the latest on the pandemic.
U.S. shatters record for COVID cases
The U.S. recorded a record-breaking 153,000 newly confirmed cases of COVID-19 nationwide yesterday. Some hospitals are reporting a shortage in staffing, beds and personal protective equipment. Dr. Uzma Syed, an infectious disease specialist at the Good Samaritan Hospital Medical Center on Long Island, joins CBSN to discuss the fight against the pandemic.
Markets rally after election & vaccine news
Melissa Armo, founder and owner of Stock Swoosh, joins CBSN to discuss how the outcome of the presidential election and news about progress towards a COVID-19 vaccine could affect the stock market.
Pfizer gearing up to distribute COVID-19 vaccine
"My biggest fear is that we're dealing with a surge at the same time that we're trying to vaccinate," said New Jersey Health Commissioner Judith Persichilli.
Pfizer official talks COVID-19 vaccine
Pfizer chief scientific officer Dr. Mikael Dolsten spoke with CBS News' Dr. Jon LaPook after the drugmaker announced that human trials suggest its coronavirus vaccine is more than 90% effective.
11/10/20: Red and Blue
AG Barr allows prosecutors to probe voter fraud; Sydney Barber makes history at U.S. Naval Academy
Biden welcomes progress on COVID vaccine
President-elect Joe Biden is welcoming the progress being made toward a coronavirus vaccine, but said the process must be transparent to ensure confidence and safety. Bina Venkataraman, an editorial page editor for the Boston Globe and former adviser to President Obama's Council of Advisors on Science and Technology during the Ebola pandemic, spoke to CBSN's "Red & Blue" host Elaine Quijano about the efforts to ensure public trust in a coronavirus vaccine.
Military faces challenges with distribution of COVID vaccine
Dr. Anthony Fauci said vaccines will likely be available for most Americans who want it by April. In CBS News' series "Racing to a Cure," David Martin takes a look at what it will take to distribute those first doses.
Progress in treating COVID as cases surge
Pfizer says its COVID-19 vaccine is 90% effective in testing so far, and the FDA has given emergency approval to a new antibody treatment, as the world braces for a tough winter during the pandemic. Dr. Amesh Adalja joined CBSN to discuss the impact.
Alex Azar on Pfizer vaccine announcement
Secretary of Health and Human Services Alex Azar joins "CBS This Morning" following drug maker Pfizer's announcement that its coronavirus vaccine is 90% effective. Azar discusses his hope for the vaccine, how the government will distribute it and how the White House will transition to a Biden administration in January.
Markets soar on Pfizer vaccine, election news
Stock markets got a shot in the arm after promising news of a vaccine and election results were announced. CBS News business analyst Jill Schlesinger explains the factors behind the market surge.
New hope for a COVID-19 vaccine
Pfizer says its new coronavirus vaccine has proven to be more than 90% effective, and it could be used before the end of the year. Dr. Jon LaPook reports.
Pfizer says COVID vaccine is over 90% effective
Drugmaker Pfizer said its coronavirus vaccine trials are 90% effective. Meanwhile, President-elect Joe Biden announces new COVID-19 plans for the country as the U.S. surpasses 10 million confirmed cases. Internal medicine specialist and immunologist Dr. Neeta Ogden joins CBSN's Elaine Quijano to discuss the latest news about the pandemic.
live updates
Senate rejects funding bills again as government shutdown continues into second week
The government shutdown stretched into its sixth day on Monday with no signs of an imminent resolution. Follow live updates here.
Illinois, Chicago sue to block Trump deployment of National Guard
The state of Illinois and city of Chicago are suing the Trump administration over their plans to deploy the National Guard.
Israel and Hamas begin indirect Gaza ceasefire talks in Egypt
President Trump wants Israeli and Hamas negotiators to "move fast" in new talks aimed at securing a ceasefire in the Gaza war, spurred by his 20-point plan.
U.S. to take ownership stake in Trilogy Metals, which has Alaskan mining claims
Interior Secretary Doug Burgum said the "ownership in that company will benefit the American people."
Ex-NFL quarterback Mark Sanchez charged with felony over violent altercation
Mark Sanchez was hospitalized with multiple stab wounds following a violent altercation over the weekend.
Air traffic controllers told to keep working during government shutdown
National Air Traffic Controllers Association tells its members that failing to report to work could cost them their job.
FBI analyzed some Republican lawmakers' phone records as part of Trump Jan. 6 probe
The FBI in 2023 analyzed phone records of more than a half dozen Republican lawmakers as part of an investigation into efforts by President Trump to overturn the results of the 2020 presidential election, GOP senators say.
Costco now sells Ozempic and Wegovy at its pharmacies
A one-month supply of Ozempic and Wegovy will now cost $499 out of pocket for Costco shoppers.
Supreme Court won't take up Ghislaine Maxwell's appeal of conviction
The Supreme Court on Monday said it will not take up a bid by Ghislaine Maxwell to overturn her 2021 conviction for sex trafficking.